LGR5 and neoplasm: Our observations support the proposed role of YAP as a tumor suppressor in metastatic CRC, where it can inhibit the Wnt pathway by reprogramming LGR5+ cells and, in vivo, by reducing Wnt activity (Cheung et al., 2020).